Drug Development Research

Cover image for Vol. 76 Issue 1

Edited By: Michael Williams

Impact Factor: 0.734

ISI Journal Citation Reports © Ranking: 2013: 55/58 (Chemistry Medicinal); 219/256 (Pharmacology & Pharmacy)

Online ISSN: 1098-2299

Recently Published Issues

See all

Having trouble accessing the journal?

Recommend to your library

All readers can access journal abstracts and a table of contents for each issue, but if your institution subscribes you get even more! Pages and pages of groundbreaking new research is online and available for you to view, cite and read- from cover- to- cover. Get in the know today and recommend that your library subscribe.

Special Issues and Articles

Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer

Denong Wang, Laila Dafik1, Rosalie Nolley, Wei Huang, Russell D. Wolfinger, Lai-Xi Wang, Donna M. Peehl

Antioligomannose Picture

Prostate cancer (PCa) is the most common noncutaneous malignancy in men. Based on autopsy studies, a significant number of American men in their 30s already have cancer in their prostates; this frequency rises to about 80% for men in their 70s. Despite such a high incidence of PCa, only 8% of men in the United States in their lifetime present with clinically significant disease that affects their quality of life [Stamey et al., 1993], and only 3% of all men in the United States die of PCa [Ries, 1994]. No other human cancer possesses such an enormous disparity between the very high incidence of malignancy microscopically and the relatively low death rate. Read on

Read Special Issue: Biomarkers in Drug Development and Companion Diagnostics